Watchlist Manager

Watchlist

Price: 9.84 CNY -1.2% Market Closed

Market Cap: ¥19.3B

T	Tonghua Dongbao Pharmaceutical Co Ltd SSE:600867	CN
H	HeNan Splendor Science & Technology Co Ltd SZSE:002296	CN

Balance Sheet

Currency: CNY

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	6	19	4	14	28	9	10	19	47	63	244	125	216	202	212	236	336	356	297	593	865	788	1 104	587
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	865	788	1 104	587
Cash Equivalents	6	19	4	14	28	9	10	19	47	63	244	125	216	202	212	236	336	356	297	593	0	0	0	0
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	203	150	37	58	56	55
Total Receivables	495	613	629	569	523	411	402	461	442	412	480	388	403	431	427	483	569	665	699	596	673	511	917	569
Accounts Receivables	281	265	319	320	292	321	300	328	315	316	346	296	338	392	385	450	544	558	552	510	559	422	793	487
Other Receivables	214	348	311	249	232	90	102	133	127	97	134	92	64	38	42	33	25	107	147	86	113	88	124	83
Inventory	99	96	127	141	140	140	146	146	170	187	198	233	344	630	955	1 048	974	901	629	538	538	654	705	736
Other Current Assets	110	61	30	17	94	28	53	46	63	68	132	123	145	50	40	443	361	351	99	45	50	45	34	59
Total Current Assets	709	789	790	740	785	588	610	671	722	731	1 054	869	1 107	1 312	1 634	2 210	2 240	2 273	1 927	1 922	2 162	2 056	2 816	2 006
PP&E Net	622	673	732	808	874	1 100	1 224	1 227	1 180	1 148	1 087	1 233	1 260	1 280	1 813	1 888	1 912	2 056	2 164	2 384	2 603	2 745	2 704	2 754
PP&E Gross	622	673	732	808	874	1 100	1 224	1 227	1 180	1 148	1 087	1 233	1 260	1 280	1 813	1 888	1 912	2 056	2 164	2 384	2 603	2 745	2 704	2 754
Accumulated Depreciation	133	145	187	230	281	333	381	437	502	586	682	766	815	903	1 014	1 135	1 265	1 381	1 503	1 613	1 484	1 596	1 695	1 791
Intangible Assets	35	31	31	32	24	94	104	93	85	78	70	69	81	82	102	199	194	389	473	609	797	1 069	1 338	1 576
Goodwill	0	0	0	0	0	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	65	76	242	226	202	259	298	153	244	209	139	173	213	243	193	333	368	385	429	528	557	458	534	724
Other Long-Term Assets	0	0	0	0	0	34	28	22	21	21	28	36	33	39	47	45	40	361	358	360	402	422	378	318
Other Assets	0	0	0	0	0	5	5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	1 431 N/A	1 569 +10%	1 795 +14%	1 806 +1%	1 885 +4%	2 078 +10%	2 269 +9%	2 171 -4%	2 251 +4%	2 186 -3%	2 377 +9%	2 380 +0%	2 695 +13%	2 956 +10%	3 788 +28%	4 675 +23%	4 753 +2%	5 463 +15%	5 350 -2%	5 803 +8%	6 520 +12%	6 750 +4%	7 771 +15%	7 379 -5%
Liabilities
Accounts Payable	29	40	41	45	44	43	41	48	41	47	38	31	39	52	53	91	61	132	69	68	75	81	116	97
Accrued Liabilities	33	28	38	36	38	41	38	39	42	9	2	6	18	14	16	18	19	23	19	16	32	12	31	51
Short-Term Debt	3	3	249	182	208	232	324	323	223	64	63	79	253	310	873	410	0	450	125	0	0	0	150	419
Current Portion of Long-Term Debt	0	0	0	90	130	20	0	0	0	0	30	0	30	0	0	20	0	0	0	0	0	0	0	4
Other Current Liabilities	11	18	15	27	30	40	19	15	16	50	31	20	36	85	85	100	95	87	92	124	162	70	223	94
Total Current Liabilities	76	89	343	380	450	376	422	425	321	169	163	136	375	461	1 027	639	175	691	305	208	269	162	520	665
Long-Term Debt	0	50	50	100	48	270	270	270	269	267	122	239	256	298	250	60	0	0	0	0	0	0	0	273
Deferred Income Tax	0	0	0	0	0	0	0	0	16	4	1	2	2	3	0	0	0	0	0	0	0	8	7	12
Minority Interest	7	41	43	46	45	44	42	40	34	33	32	30	25	23	20	6	10	10	8	6	5	5	5	17
Other Liabilities	2	3	1	1	46	46	43	43	17	14	13	12	45	34	32	31	40	38	36	36	31	31	28	28
Total Liabilities	84 N/A	182 +115%	437 +141%	526 +20%	589 +12%	735 +25%	777 +6%	778 +0%	658 -15%	487 -26%	331 -32%	418 +26%	703 +68%	819 +16%	1 329 +62%	736 -45%	225 -69%	739 +229%	350 -53%	249 -29%	305 +22%	206 -32%	560 +172%	995 +78%
Equity
Common Stock	325	325	325	325	325	369	369	369	479	575	776	776	932	1 030	1 136	1 422	1 711	2 034	2 034	2 034	2 034	1 994	1 994	1 982
Retained Earnings	281	321	293	214	231	279	357	404	481	660	1 024	931	960	960	1 144	1 331	1 599	1 753	2 157	2 679	3 567	4 053	4 725	4 186
Additional Paid In Capital	741	741	741	741	741	696	767	622	633	465	246	254	89	158	208	1 202	1 215	933	935	1 034	1 006	642	623	509
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	29	29	17	0	0	134	201	398	150	135	300
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	11	19	0	1	3	5	8	8	7	6	5	7
Total Equity	1 347 N/A	1 387 +3%	1 358 -2%	1 280 -6%	1 296 +1%	1 343 +4%	1 492 +11%	1 394 -7%	1 593 +14%	1 700 +7%	2 046 +20%	1 962 -4%	1 991 +2%	2 138 +7%	2 459 +15%	3 939 +60%	4 528 +15%	4 724 +4%	5 000 +6%	5 554 +11%	6 215 +12%	6 544 +5%	7 211 +10%	6 384 -11%
Total Liabilities & Equity	1 431 N/A	1 569 +10%	1 795 +14%	1 806 +1%	1 885 +4%	2 078 +10%	2 269 +9%	2 171 -4%	2 251 +4%	2 186 -3%	2 377 +9%	2 380 +0%	2 695 +13%	2 956 +10%	3 788 +28%	4 675 +23%	4 753 +2%	5 463 +15%	5 350 -2%	5 803 +8%	6 520 +12%	6 750 +4%	7 771 +15%	7 379 -5%
Shares Outstanding
Common Shares Outstanding	2 048	2 048	2 048	2 048	2 048	1 948	1 948	1 948	1 948	1 948	1 948	1 948	1 948	1 958	1 963	2 048	2 054	2 034	2 023	2 018	2 008	1 991	1 992	1 982

Income Statement Balance Sheet Cash Flow Statement

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Balance Sheet

Balance Sheet Decomposition
Tonghua Dongbao Pharmaceutical Co Ltd

Balance Sheet
Tonghua Dongbao Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Tonghua Dongbao Pharmaceutical Co Ltd SSE:600867

Balance Sheet

Balance Sheet Decomposition Tonghua Dongbao Pharmaceutical Co Ltd

Balance Sheet Tonghua Dongbao Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Balance Sheet Decomposition
Tonghua Dongbao Pharmaceutical Co Ltd

Balance Sheet
Tonghua Dongbao Pharmaceutical Co Ltd